Mark Connors

National Institutes of Health

Papers

1

Total Citations

21

H-Index

1

About

Dr. Mark Connors is a leading immunologist whose research focuses on the mechanisms of immune control in HIV-1 infection, with a particular emphasis on the role of neutralizing antibodies. His major contributions include the development and refinement of high-throughput HIV-1 microneutralization assays, which have become essential tools for evaluating the potency and breadth of antibody responses against the viral Envelope glycoprotein. This work, notably detailed in his 2013 paper (21 citations), has enabled more precise and scalable assessments of candidate vaccines and immunotherapies. Dr. Connors’ research has significantly advanced our understanding of how the immune system can be harnessed to combat HIV, providing critical insights into the design of effective antibody-based interventions. His innovative assay techniques have been widely adopted by the field, underscoring his impact on HIV research and his role in shaping the path toward a functional cure.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
High throughput HIV-1 microneutralization assay
21 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: National Institutes of Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago